cmAngio® vs Cardiologs Holter Platform
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your practice aims to enhance proactive cardiovascular risk assessment for women by leveraging existing mammography data. This tool is ideal for integrating early cardiovascular insights into routine breast screenings without requiring additional radiation or procedures, offering a valuable secondary analysis for patient health.
View cmAngio® →Choose Cardiologs Holter Platform if…
Choose the Cardiologs Holter Platform if your cardiology department requires a highly efficient and accurate solution for analyzing Holter ECG data. This AI-powered, cloud-based platform is best suited for rapidly detecting a wide range of arrhythmias and streamlining diagnostic workflows, particularly when seeking vendor-neutral compatibility and reduced analysis times.
View Cardiologs Holter Platform →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | Cardiologs Holter Platform |
|---|---|---|
| Pricing | Paid, out-of-pocket | Unknown |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | Cloud |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardiologs Holter PlatformCardiologs Holter Platform (Tool B) offers significant usability benefits by reducing Holter analysis time by approximately 42% and providing an ergonomic, cloud-based interface for efficient workflow. Its vendor-neutral compatibility with multiple Holter devices and a 'ShareSpace' feature for easy collaboration further enhance its practical usability in diverse clinical settings.
Clinical Value
Cardiologs Holter PlatformWhile both tools offer strong clinical value, Cardiologs Holter Platform (Tool B) provides more detailed and quantifiable clinical validation, including a significant reduction in AF false positives (from 17.2% to 1.5%) and a 29% increase in VT detection sensitivity. It was also the first FDA-cleared deep learning AI for ECG analysis in 2017 and is supported by a database of over 200 million recordings.
Pricing & Value
Cardiologs Holter PlatformNeither tool offers publicly transparent pricing, requiring direct contact for quotes. However, Cardiologs Holter Platform (Tool B) provides a clearer pricing model of 'Pay per ECG regardless the number of users', offering a more predictable and scalable cost structure for healthcare providers.
Enterprise Readiness
Cardiologs Holter PlatformCardiologs Holter Platform (Tool B) demonstrates superior enterprise readiness through explicit integration with EMR systems via Philips IntelliBridge Enterprise, secure data hosting on ISO/IEC 27001 certified AWS servers, and a clear statement of having a Business Associate Agreement (BAA). These features indicate a more robust and documented infrastructure for large-scale healthcare deployments.
Innovation
TieBoth tools present significant innovation in their respective domains. cmAngio (Tool A) offers a novel application of AI to extract new cardiovascular risk insights from existing mammograms, effectively creating a '2-for-1' screening. Cardiologs Holter Platform (Tool B) was the first FDA-cleared deep learning AI for ECG analysis and has received an innovation award for its ability to analyze ECG recordings faster and more reliably.
Support & Docs
Cardiologs Holter PlatformCardiologs Holter Platform (Tool B) clearly outlines how to access technical support through its platform's 'Help' menu and provides links to various documentation, including brochures and white papers. In contrast, cmAngio (Tool A) lacks explicit details on support and documentation in the provided information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | Cardiologs Holter Platform |
|---|---|---|
| Tool Name | cmAngiou00ae | Cardiologs Holter Platform |
| Company | CureMetrix | Philips France Commercial |
| Primary Clinical Focus | Detecting Breast Arterial Calcifications (BAC) on mammograms for cardiovascular health insights and early risk assessment. | AI-powered, cloud-based solution for fast and accurate Holter ECG analysis to streamline cardiac diagnostics. |
| Detection/Analysis Capability | AI-based detection of Breast Arterial Calcifications (BAC); processes FFDM and DBT exams; provides visualization of BAC location. | AI-powered deep learning technology for ECG analysis; detects over 20 types of arrhythmias; reduces Holter analysis time by approximately 42%. |
| Compatibility/Integration | Compatible with any DICOM-compliant viewer. | Vendor-neutral compatibility with multiple Holter devices; integration with Electronic Medical Record (EMR) systems (Philips IntelliBridge Enterprise). |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and Cardiologs Holter Platform.